This process involves the inhibition of the GSK-3 signaling pathway, leading to the activation of β-catenin, which subsequently inhibit tumor cell proliferative capacity and impairs CD8+ T cell infiltration into tumors (6, 33). This evidence concerns the gene CD8A and neoplasm.